Kesimpta 20 mg pre-filled pen guide
Quick summary Kesimpta 20 mg solution for injection in a pre-filled pen is used for relapsing forms of multiple sclerosis. This guide explains what it is, how the pen is generally used, what side...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary
Kesimpta 20 mg solution for injection in a pre-filled pen is used for relapsing forms of multiple sclerosis. This guide explains what it is, how the pen is generally used, what side effects are commonly mentioned, and what to confirm in the official leaflet or with your healthcare professional.
Medical disclaimer: This article is for general information only and does not replace advice from a doctor, nurse, or pharmacist. Do not use it to diagnose a condition, and do not change how you use any medicine without professional guidance.
Kesimpta 20 mg solution for injection in a pre-filled pen is a treatment used for certain relapsing forms of multiple sclerosis (MS). The active ingredient is ofatumumab, which targets CD20 on B-cells.
This page gives a clear overview of how the medicine is described, how the pen is generally administered, and what safety points are worth checking before and during treatment.
What is Kesimpta and how does it work?
Kesimpta contains ofatumumab, a medicine that binds to CD20 on B-cells. B-cells are involved in the autoimmune process of MS. By reducing these cells, Kesimpta helps lower the frequency of relapses and may slow disease progression in relapsing forms of MS.
The pre-filled pen format is designed to support self-administration, which can make treatment more convenient for some patients.
Key points about the pre-filled pen
- Self-administration: The pen is intended for use at home after proper training.
- Fixed presentation: The product is supplied as a 20 mg solution for injection in a pre-filled pen.
- Support available: Some patients may receive training or support through a patient support program.
How the Kesimpta pen is generally used
Always follow the instructions provided with your medicine and the guidance of your healthcare team. The steps below are a general overview only.
- Prepare a clean, well-lit area before injection.
- Check the pen and make sure it looks intact.
- Allow the medicine to reach room temperature if instructed in the leaflet.
- Choose an injection site such as the thigh or abdomen, avoiding areas with scars or visible veins.
- Clean the skin as directed before injection.
- Use the pen exactly as shown in the official instructions.
- Dispose of the used pen safely according to local guidance.
If you are unsure about any step, ask a pharmacist, nurse, or doctor to show you the correct technique.
Commonly mentioned side effects
Like all medicines, Kesimpta may cause side effects. The original content mentions the following:
- Injection site reactions such as redness, pain, or swelling
- Infections, because the medicine affects the immune system
- Headache
- Fatigue
Seek medical advice if side effects are severe, persistent, or worrying. If you have a history of allergies or active hepatitis B, this is especially important to discuss with your healthcare professional before treatment.
Injection site tips
The injection site can affect comfort. The original content highlights these practical points:
- Common sites include the thigh and abdomen.
- Rotate sites to help reduce skin irritation or lumps.
- Keep the area clean before injection.
For the most accurate site guidance, check the official patient leaflet or ask your healthcare team.
How long does Kesimpta take to work?
Response time can vary from person to person. The original content notes that some patients may notice improvement within a few weeks, while the full benefit may take a few months. Clinical studies showed reductions in relapse rates within the first year.
Regular follow-up appointments are important so your healthcare team can monitor progress and review treatment as needed.
What to verify in the official leaflet
If you are using Kesimpta, it is sensible to confirm the following in the official leaflet or with a pharmacist:
- How the pen should be stored
- How long it can remain at room temperature
- How to prepare the injection correctly
- What to do if a dose is missed
- Which symptoms need urgent medical attention
| Topic | What the article says |
|---|---|
| Active ingredient | Ofatumumab |
| Use | Relapsing forms of multiple sclerosis |
| Format | 20 mg solution for injection in a pre-filled pen |
| Commonly mentioned side effects | Injection site reactions, infections, headache, fatigue |
FAQs about Kesimpta
▸ What is a Kesimpta pen used for?
It is used for the treatment of relapsing forms of multiple sclerosis and delivers ofatumumab in a pre-filled pen format.
▸ How is Kesimpta usually given?
It is given as a subcutaneous injection using the pre-filled pen, following the instructions in the official leaflet and training from a healthcare professional.
▸ What are the common side effects mentioned in this guide?
The original content mentions injection site reactions, infections, headache, and fatigue.
▸ Where is the injection usually given?
The original content mentions the thigh and abdomen as preferred sites, with rotation of sites to help reduce irritation.
▸ How long can Kesimpta stay out of the fridge?
The original content states that it can remain at room temperature for up to 30 days once removed from the refrigerator. Always confirm this in the official leaflet for your specific pack.
▸ When should I ask for medical advice?
Ask for medical advice if you have severe or persistent side effects, signs of infection, or any condition such as allergies or hepatitis B that may affect treatment safety.
Safety reminder: Use Kesimpta only as prescribed and follow the official patient leaflet and training provided by your healthcare team. If anything about the injection, storage, or side effects is unclear, check with a pharmacist or doctor before using the medicine.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
- Kesimpta official patient information leaflet
- FDA prescribing information for Kesimpta
- NHS medicines information on ofatumumab
- Multiple Sclerosis Trust information on disease-modifying therapies
- European Medicines Agency product information
To improve this article with specific references, add a custom field named _aio_sources in the post editor and write one source per line using: Source title|Source URL.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.